Market Tracker

01/27 7:08am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

95.21
Data as of Jan 26
 +1.78 / +1.91%
Today’s Change
47.03
Today|||52-Week Range
111.49
-1.85%
Year-to-Date

Today’s Trading

Previous close93.42
Today’s open93.41
Day’s range-- - --
Volume861,859
Average volume (3 months)710,001
Market cap$7.7B
Dividend yield--
Data as of 01/26/2015

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-259.48%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book22.03

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+0.99+1.62%
ISISIsis Pharmaceuticals...+1.62+2.27%
ICLRICON PLC+0.65+1.14%
PRXLPAREXEL Internationa...+0.76+1.22%
Data as of 01/26/2015

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts